PKM and neoplasm: PKM2’s SUMOylation promotes interaction with ARRDC1 and secretion via exosomes into the tumor microenvironment, activating STAT3 phosphorylation in monocytes and inducing their metabolic reprogramming and differentiation into macrophages (7).